295 related articles for article (PubMed ID: 22983907)
1. Assessment of ventricular remodeling in heart failure clinical trials.
Kirkpatrick JN; St John Sutton M
Curr Heart Fail Rep; 2012 Dec; 9(4):328-36. PubMed ID: 22983907
[TBL] [Abstract][Full Text] [Related]
2. Drugs for left ventricular remodeling in heart failure.
Frigerio M; Roubina E
Am J Cardiol; 2005 Dec; 96(12A):10L-18L. PubMed ID: 16399088
[TBL] [Abstract][Full Text] [Related]
3. Myocardial recovery and the failing heart: medical, device and mechanical methods.
Goldfinger JZ; Nair AP
Ann Glob Health; 2014; 80(1):55-60. PubMed ID: 24751565
[TBL] [Abstract][Full Text] [Related]
4. Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
Linde C; Gold MR; Abraham WT; St John Sutton M; Ghio S; Cerkvenik J; Daubert C;
Eur Heart J; 2013 Sep; 34(33):2592-9. PubMed ID: 23641006
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological modulation of cardiovascular remodeling: a guide to heart failure therapy.
Remme WJ
Cardiovasc Drugs Ther; 2003 Jul; 17(4):349-60. PubMed ID: 14618097
[TBL] [Abstract][Full Text] [Related]
6. Strategies to attenuate pathological remodeling in heart failure.
Eapen Z; Rogers JG
Curr Opin Cardiol; 2009 May; 24(3):223-9. PubMed ID: 19318933
[TBL] [Abstract][Full Text] [Related]
7. [Chronic heart failure treatment in the year 2006].
De Berrazueta Fernández JR
An R Acad Nac Med (Madr); 2006; 123(3):617-30. PubMed ID: 17451101
[TBL] [Abstract][Full Text] [Related]
8. Neurohumoral activation and progression of heart failure: hypothetical and clinical considerations.
Francis GS
J Cardiovasc Pharmacol; 1998; 32 Suppl 1():S16-21. PubMed ID: 9731691
[TBL] [Abstract][Full Text] [Related]
9. Pathophysiology of chronic heart failure.
Francis GS
Am J Med; 2001 May; 110 Suppl 7A():37S-46S. PubMed ID: 11334774
[TBL] [Abstract][Full Text] [Related]
10. Remodeling in systolic heart failure: therapeutic implications.
Chatterjee K
Indian Heart J; 2004; 56(2):99-109. PubMed ID: 15377130
[No Abstract] [Full Text] [Related]
11. Effects of ACE-inhibitors and beta-blockers on left ventricular remodeling in chronic heart failure.
Khattar RS
Minerva Cardioangiol; 2003 Apr; 51(2):143-54. PubMed ID: 12783070
[TBL] [Abstract][Full Text] [Related]
12. Reverse Cardiac Remodeling: A Marker of Better Prognosis in Heart Failure.
Reis Filho JR; Cardoso JN; Cardoso CM; Pereira-Barretto AC
Arq Bras Cardiol; 2015 Jun; 104(6):502-6. PubMed ID: 26131706
[TBL] [Abstract][Full Text] [Related]
13. Potential novel pharmacological therapies for myocardial remodelling.
Landmesser U; Wollert KC; Drexler H
Cardiovasc Res; 2009 Feb; 81(3):519-27. PubMed ID: 19019834
[TBL] [Abstract][Full Text] [Related]
14. Relation between left ventricular remodeling and clinical outcomes in heart failure patients with left ventricular systolic dysfunction.
Udelson JE; Konstam MA
J Card Fail; 2002 Dec; 8(6 Suppl):S465-71. PubMed ID: 12555159
[TBL] [Abstract][Full Text] [Related]
15. Influence of aetiology on long-term effects of resynchronization on cardiac structure and function in patients treated with β-blockers.
Zacà V; Baiocchi C; Gaddi R; Gentilini R; Lunghetti S; Padeletti M; Pagliaro A; Furiozzi F; Mondillo S; Favilli R
J Cardiovasc Med (Hagerstown); 2011 Apr; 12(4):227-33. PubMed ID: 21252694
[TBL] [Abstract][Full Text] [Related]
16. Neurohormonal and Transcatheter Repair Strategies for Proportionate and Disproportionate Functional Mitral Regurgitation in Heart Failure.
Packer M; Grayburn PA
JACC Heart Fail; 2019 Jun; 7(6):518-521. PubMed ID: 31078484
[No Abstract] [Full Text] [Related]
17. Feasibility of arresting the process of remodeling.
Somasundaram PE; Chandrashekhar Y
Med Clin North Am; 2004 Sep; 88(5):1193-207, x. PubMed ID: 15331313
[TBL] [Abstract][Full Text] [Related]
18. Implication of cardiac remodeling in heart failure: mechanisms and therapeutic strategies.
Takano H; Hasegawa H; Nagai T; Komuro I
Intern Med; 2003 Jun; 42(6):465-9. PubMed ID: 12857042
[TBL] [Abstract][Full Text] [Related]
19. Congestive heart failure: what should be the initial therapy and why?
Chatterjee K
Am J Cardiovasc Drugs; 2002; 2(1):1-6. PubMed ID: 14727993
[TBL] [Abstract][Full Text] [Related]
20. Natural history of end-stage LV dysfunction: has it improved from the classic Franciosa and Cohn Graph?
Jacoby D; Albajrami O; Bellumkonda L
Cardiol Clin; 2011 Nov; 29(4):485-95. PubMed ID: 22062195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
